Tevogen Bio has a total of 10 patents globally, out of which 3 have been granted. Of these 10 patents, more than 80% patents are active. United States of America is where Tevogen Bio has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Tevogen Bio.
Tevogen Bio was founded in the year 2020. The Company operates as a biotechnology company. The Company develops proprietary cell and gene therapy platforms to innovate breakthrough and accessible immunotherapeutic for life threatening cancers and viral infections for which limited treatment options are available.
Do read about some of the most popular patents of Tevogen Bio which have been covered by us in this article and also you can find Tevogen Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tevogen Bio patent portfolio.
How many patents does Tevogen Bio have?
Tevogen Bio has a total of 10 patents globally. These patents belong to 3 unique patent families. Out of 10 patents, 8 patents are active.
How Many Patents did Tevogen Bio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Tevogen Bio Applications Filed | Tevogen Bio Patents Granted |
| 2023 | 1 | – |
| 2022 | 2 | 1 |
| 2021 | 6 | 2 |
| 2020 | 1 | – |
How many Tevogen Bio patents are Alive/Dead?
How Many Patents did Tevogen Bio File in Different Countries?
Countries in which Tevogen Bio Filed Patents
| Country | Patents |
| United States Of America | 5 |
| Australia | 1 |
| Canada | 1 |
| Europe | 1 |
Where are Research Centres of Tevogen Bio Patents Located?
The Research Centre for all the Tevogen Bio patents is the United States of America.
Best Tevogen Bio Patents
US11191827B1 is the most popular patent in the Tevogen Bio portfolio. It has received 2 citations so far from company like Atossa Therapeutics.
What Percentage of Tevogen Bio US Patent Applications were Granted?
Tevogen Bio (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 75.0%.
Below are the key stats of Tevogen Bio patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Tevogen Bio?
| Law Firm | Total Applications | Success Rate |
| Hogan Lovells Us Llp | 4 | 75.00% |
List of Tevogen Bio Patents
| Tevogen Bio Patents | Title |
| US11219684B1 | Covid-19 Peptide Specific T-Cells And Methods Of Treating And Preventing Covid-19 |
| US11207401B1 | Covid-19 Peptide Specific T-Cells And Methods Of Treating And Preventing Covid-19 |
| US11191827B1 | Covid-19 Peptide Specific T-Cells And Methods Of Treating And Preventing Covid-19 |
| US20230372398A1 | Virus Specific T-Cells And Methods Of Treating And Preventing Viral Infections |
| EP4259163A2 | Virus Specific T-Cells And Methods Of Treating And Preventing Viral Infections |
| AU2021397278A1 | Virus Specific T-Cells And Methods Of Treating And Preventing Viral Infections |
| WO2023009770A1 | Methods For Developing Cd3+Cd8+ Cells Against Multiple Viral Epitopes For Treatment Of Viral Infections Including Variants Evolving To Escape Previous Immunity |
| CA3201851A1 | Virus Specific T-Cells And Methods Of Treating And Preventing Viral Infections |
| US20220202865A1 | Virus Specific T-Cells And Methods Of Treating And Preventing Viral Infections |
| WO2022125746A3 | Virus Specific T-Cells And Methods Of Treating And Preventing Viral Infections |
What are Tevogen Bio key innovation segments?
What Technologies are Covered by Tevogen Bio?
The chart below distributes patents filed by Tevogen Bio